UFA-22028-67679 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Survey response — day 14, dose 1
MedDRA: Fatigue, Headache, Lacrimation increased, Nasal congestion — Feeling: Poor · Be unable to work

Free text: Headache fatigue nadal congestion eye tearing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-01
Report sent to call center — day 14, dose 1
Be unable to work

1 call case(s)
2021-01-08
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-06-18
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-01

Symptoms: Headache fatigue nadal congestion eye tearing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Lacrimation increased	✓	✓	✓
SD	Nasal congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release